More on Opko Q1 results

OPKO Health (OPK) total revenues: $22.3M (-28.8%); product revenues: $19.8M (+27.7%); operating loss: ($30.3M) (-345.6%); loss/share: ($0.11) (unch); cash & equiv: $156.4M (-15.8%).

4Kscore Test launched through Nashville, TN CLIA lab on March 31.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs